7774 Share Price Performance
JP¥0
-488.00 (-100.00%)
Price JP¥0
Share Pricen/a
Japan Tissue Engineering Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
7774 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Japan Tissue Engineering Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 30, 2026
- -10.84
- 61.96%
- -17.44%
- 0%
About 7774
- Founded
- 1999
- Employees
- 200
- CEO
- WebsiteView website
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Lab Site Project segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it offers EPI-MODEL, a reconstructed human epidermis model. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. operates as a subsidiary of Teijin Limited.
